CELLMOVER AS
Pre-clinical immunotherapy company optimizing immune cell targeting for cancer.
Översikt
- 7
- Anställda
- 4.5milj NOK
- Omsättning
- 2015
- Grundat
Nyckelbeslutsfattare
Miriam Aarsund Larsen
CEO
Marit Inngjerdingen
Founder & Chairman
Eirik Næss-Ulseth
BD Advisor
Eline M. Scheie-Ahlgren
Associate scientist
+2 fler kontakter i Funnelfeedr
Beskrivning
Cellmover is a pre-clinical stage immunotherapy company based in Oslo, Norway. Their core mission is optimizing the tools of the immune system to expand the application of immunotherapies across various cancers. The company has developed a proprietary library of nanobodies and peptides specifically...